申请人:——
公开号:US05468748A1
公开(公告)日:1995-11-21
The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
本发明涉及9H-吲哚[1,2-b]吡嗪-3(4H)-酮和9H-吲哚[1,2-b]吡嗪-2,3(1H,4H)-二酮或其互变异构体,这些化合物可用于治疗基于NMDA受体复合物上的甘氨酸结合位点拮抗作用的神经和精神疾病。